CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,427 | – | 10,836 | +16831.2% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 64 | -97.4% | 0.00% | – |
Q3 2022 | $2,000 | +100.0% | 2,440 | +260.4% | 0.00% | – |
Q2 2022 | $1,000 | -94.7% | 677 | -91.9% | 0.00% | – |
Q1 2022 | $19,000 | -45.7% | 8,319 | -34.2% | 0.00% | -100.0% |
Q4 2021 | $35,000 | +94.4% | 12,635 | +328.7% | 0.00% | – |
Q3 2021 | $18,000 | -56.1% | 2,947 | -82.3% | 0.00% | -100.0% |
Q1 2021 | $41,000 | +215.4% | 16,672 | +252.6% | 0.00% | – |
Q4 2020 | $13,000 | -31.6% | 4,728 | -62.1% | 0.00% | – |
Q3 2020 | $19,000 | +850.0% | 12,472 | +1013.6% | 0.00% | – |
Q2 2020 | $2,000 | -75.0% | 1,120 | -85.5% | 0.00% | -100.0% |
Q2 2019 | $8,000 | +700.0% | 7,722 | +784.5% | 0.00% | – |
Q1 2019 | $1,000 | -80.0% | 873 | -81.7% | 0.00% | – |
Q4 2018 | $5,000 | -54.5% | 4,779 | +166.8% | 0.00% | -100.0% |
Q3 2018 | $11,000 | -85.7% | 1,791 | -75.0% | 0.00% | -75.0% |
Q2 2018 | $77,000 | -40.8% | 7,174 | -41.1% | 0.00% | -63.6% |
Q1 2018 | $130,000 | +441.7% | 12,175 | +339.8% | 0.01% | +450.0% |
Q3 2017 | $24,000 | 0.0% | 2,768 | +2.9% | 0.00% | -33.3% |
Q4 2016 | $24,000 | -85.2% | 2,690 | -71.1% | 0.00% | -81.2% |
Q3 2016 | $162,000 | +3950.0% | 9,321 | +1764.2% | 0.02% | – |
Q2 2016 | $4,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |